ARCHIVES

New Saccharin Studies Convince FDA It A Carcinogen

This article is from The Cancer Letter archive.

Vol. 03 No. 28 | July 15, 1977

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999

CCI Will Tackle Reimbursement Issue

May 16, 1980

In Brief: DeVita wins $150,000 Pezcoller Prize; BreastPac To “Storm” Capitol On Bastille Day For More $$

July 8, 1988

Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future

March 1, 1996